Loading
Latest filing published 02 Jun 2026 for Medicenna Therapeutics Corp., €4,039. Read the official filing
Richard S. Sutin appears in our data through filings on Medicenna Therapeutics Corp. shares, published by SEDI. Between 12 February 2026 and 28 May 2026, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 2 June 2026 came the latest disclosure, a transaction for €4,039 in Medicenna Therapeutics Corp. The median gap between a trade and its publication by SEDI is 5 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations